Case Report
Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma
Table 1
Baseline patient characteristics and laboratory findings.
| ||||||||||||||||||||||||||||||||||||||||||
ACTH, adrenocorticotropic hormone; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; BP, blood pressure; DHEA-S, dehydroepiandrosterone sulfate; DST, dexamethasone suppression test; HbA1c, glycated hemoglobin A1c; LDL, low-density lipoprotein; TG, triglyceride; UFC, urinary free cortisol. |